By Jennifer Chiou
New York, Jan. 15 - Deutsche Bank AG, London Branch priced $2,695,500 of 0% contingent absolute return autocallable optimization securities due Jan. 20, 2015 linked to Alexion Pharmaceuticals, Inc. shares, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will be called at par of $10 plus an annualized call premium of 11% if Alexion stock closes at or above the initial share price on any quarterly observation date.
If the notes are not called and the stock finishes at or above the trigger price, 70% of the initial share price, the payout at maturity will be par plus the absolute value of the stock return.
Otherwise, investors will be fully exposed to any losses.
UBS Financial Services Inc. and Deutsche Bank Securities are the agents.
| Issuer: | Deutsche Bank AG, London Branch
|
| Issue: | Contingent absolute return autocallable optimization securities
|
| Underlying stock: | Alexion Pharmaceuticals, Inc. (Symbol: ALXN)
|
| Amount: | $2,695,500
|
| Maturity: | Jan. 20, 2015
|
| Coupon: | 0%
|
| Price: | Par of $10.00
|
| Payout at maturity: | If final share price is greater than or equal to trigger price, par plus absolute value of stock return; otherwise, full exposure to stock decline
|
| Call: | At par plus 11% per year if Alexion stock closes at or above initial share price on any quarterly observation date
|
| Initial share price: | $135.21
|
| Trigger price: | $94.65, 70% of initial share price
|
| Pricing date: | Jan. 10
|
| Settlement date: | Jan. 15
|
| Agents: | UBS Financial Services Inc. and Deutsche Bank Securities
|
| Fees: | 1.5%
|
| Cusip: | 25155P724
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
